Sir Patrick Vallance has £600,000 of shares in vaccine maker GSKArchived Message
Posted by Mary Jo on September 24, 2020, 6:52 am
Sir Patrick Vallance has a £600,000 shareholding in a pharmaceuticals giant which is racing to develop a Covid vaccine for the Government, a report has revealed.
The Chief Scientific Adviser holds the deferred bonus of 43,111 shares in GlaxoSmithKline (GSK) from his time as president of the multinational company.
Sir Patrick has already sold more than £5 million in shares he received during his tenure from 2012 to 2018, when he was appointed by the Government.
Accounts seen by the Telegraph show that Sir Patrick held 404,201 GSK shares when he resigned, worth £6.1 million at today's price.